Reconstitution and storage guide
How to bring a freeze-dried (lyophilised) research peptide into solution, measure it accurately, store it, and recognise when something has gone wrong. It covers the arithmetic, the technique and the chemistry behind each recommendation, with sources.
Before you start
A lyophilised vial holds a dry, often barely visible film or small white cake. That is normal: peptide is dispatched as a dry solid because most peptides are far more stable dry than in solution [PMID 20143256]. The mass shown on the label is the amount of peptide in the vial, not the weight of the powder, which can also include water, salts and counter-ions. The testing page explains the difference between purity (%) and peptide content (mg).
Decide three things before opening anything:
- Which diluent the compound needs (next section, and the table for every compound).
- How much diluent to add, which sets the concentration. This is a trade-off between measuring accuracy and vial capacity, covered in Concentration maths.
- How you will store and use the solution: one vial used over weeks behaves differently from aliquots used once. See Storage.
On arrival, check the outer seal and cap are intact, note the lot or batch name against the COA library, and move the vial to cold storage promptly. Short periods at room temperature during transit are normal for lyophilised material and are not in themselves a reason to discard it. If a vial arrives with a damaged seal, a cracked vial, or a cake that has visibly melted, collapsed or discoloured, do not use it. Contact us with the lot number and a photo.
Choosing a diluent
We supply three reconstitution diluents, and this guide covers those three. We have not assessed others, so we do not recommend them.
| Diluent | What it is | Preservative | Typically used for |
|---|---|---|---|
| Bacteriostatic water, pH 7.0 | Sterile water with 0.9% benzyl alcohol, buffered to neutral pH. | Yes (benzyl alcohol) | The majority of our compounds, which are listed at pH 7.0 on their product pages. |
| Bacteriostatic water, pH 5.7 | The same benzyl-alcohol-preserved water, buffered mildly acidic. | Yes (benzyl alcohol) | Compounds listed at pH 5.7, such as the copper peptide, some GHRH analogues and the melanocortins. |
| Acetic acid water, 0.6% | A dilute acetic acid solution. A 0.6% solution is about 0.1 mol/L, which puts it near pH 3 by calculation. The label on your bottle is the authority. | No. It is not bacteriostatic. | The few compounds whose product page lists an acetic acid option, mainly where gelling or solubility is the issue. |
Why the diluent matters
pH. Peptide chemistry is strongly pH-dependent. Deamidation of asparagine, for example, runs through different routes at acidic and at neutral-to-basic pH, and its rate changes markedly with pH, temperature and buffer [PMID 2395797]. Oxidation, aggregation and solubility all shift with pH too [PMID 20143256]. A compound’s listed pH is the diluent we suggest on its product page. Using the other one is not necessarily harmful, but it moves away from what the listing is based on.
Preservative. Benzyl alcohol keeps repeated entry into a vial from growing microbes, which is why bacteriostatic water is the standard diluent for a vial you will access more than once. It is not neutral for every molecule. In one published study of a recombinant protein, reconstituting a freeze-dried sample with 0.9% benzyl alcohol caused more aggregation than reconstituting with plain water [PMID 15614819]. That was a larger protein rather than a short peptide, so it does not predict what happens to any particular peptide, but it is the reason a small number of compounds are offered with an acetic acid option.
Acetic acid water has no preservative. That changes how you should handle the finished solution: assume it has less protection against contamination, enter the vial as few times as possible, keep it cold, and prefer smaller volumes or single-use aliquots. A mildly acidic solution is also not automatically “gentler”. Some bonds, such as aspartyl-proline, are more easily cleaved in acid [PMID 12212803], so use acetic acid water for the compounds that list it, not as a general substitute.
Diluent by compound
This table is generated from the same data as the product pages and the reconstitution calculator, so it cannot disagree with them. “Acetic option” means the product page lists acetic acid water as an alternative for that compound. If a compound is not marked, use bacteriostatic water at its listed pH.
For a worked volume and syringe diagram for any compound, use the reconstitution calculator.
Clean technique
A reconstituted vial is a small reservoir that is entered again and again, so contamination is the main risk to a solution you intend to keep. None of this needs special equipment, but all of it matters:
- Clean, uncluttered, still surface and clean gloves. Tie back hair, no talking over open vials.
- Swab both stoppers (the vial and the diluent bottle) with 70% isopropyl alcohol and let it dry for several seconds before entry. Wiping and immediately piercing carries wet alcohol in.
- A new sterile syringe for each transfer, never reused between vials, and never touching the stopper surface with anything that has touched something else.
- Do not touch the exposed stopper, the syringe tip or the inside of any cap.
- Equilibrate first. Cold vials opened in a warm room collect condensation. Moisture and oxygen in the vial both influence how well freeze-dried material holds up in storage [PMID 1592175, PMID 1592171], so let the sealed vial reach room temperature (about 15 to 30 minutes) before it is entered.
Step by step
- Warm the sealed vial to room temperature, away from direct sun. Check the cake and the label against your records.
- Inspect. The cake should be dry, with no brown or yellow tint, no wet patches, no cracks that reach the glass edge with liquid in them, and no particles on the glass. If something looks wrong, stop here.
- Swab the stoppers and let them dry.
- Draw the diluent volume you decided on, from the correct diluent (confirm the label and the pH).
- Add it slowly down the inside wall of the vial, not as a jet onto the cake. A gentle trickle reduces foaming and mechanical stress; peptides and proteins can unfold or aggregate at air-liquid interfaces and under agitation [PMID 20143256].
- Swirl or roll gently. Do not shake, vortex or sonicate. Most peptides dissolve within a few minutes. Do not heat the vial.
- Check the solution. It should be clear and colourless, with no particles, haze, gel or strings. Hold it against a light and a dark background. If it is not clear, see Troubleshooting before going further.
- Label it immediately (see Labelling and records) and move it to the fridge, protected from light.
A lyophilised vial may be under partial vacuum, which can draw the diluent in faster than you push it. Let it enter at its own pace rather than forcing the plunger, and keep the stream slow.
Concentration maths
Concentration is what you measured: it depends only on how much peptide is in the vial and how much diluent you added.
concentration (mcg/mL) = concentration (mg/mL) × 1,000
volume to measure (mL) = target amount (mcg) ÷ concentration (mcg/mL)
Worked example. A 10 mg vial reconstituted with 2 mL gives 10 ÷ 2 = 5 mg/mL, which is 5,000 mcg/mL. To measure out 250 mcg you need 250 ÷ 5,000 = 0.05 mL. On a 1 mL syringe marked in 100 divisions (so each division is 0.01 mL), that is 5 divisions.
Concentration table (mg/mL)
| Vial peptide | + 1 mL | + 2 mL | + 3 mL | + 5 mL |
|---|---|---|---|---|
| 5 mg | 5 | 2.5 | 1.67 | 1 |
| 10 mg | 10 | 5 | 3.33 | 2 |
| 30 mg | 30 | 15 | 10 | 6 |
| 50 mg | 50 | 25 | 16.7 | 10 |
Check the vial’s own capacity before choosing a volume: a 3 mL vial cannot take 5 mL.
Choosing the volume: accuracy against capacity
Measuring a very small volume is the biggest source of error in most workflows. If the smallest mark on your syringe is 0.01 mL, you can read it to about half a division, 0.005 mL. That error is a fixed size, so it matters far more at small volumes:
| Volume measured | Reading uncertainty (±0.005 mL) |
|---|---|
| 0.025 mL | ±20% |
| 0.05 mL | ±10% |
| 0.10 mL | ±5% |
| 0.25 mL | ±2% |
| 0.50 mL | ±1% |
So when you have a choice, add more diluent: the same amount of peptide in a larger volume is measured with a smaller relative error. The limits are the vial’s capacity, and the fact that a bigger volume means more entries into the vial (more contamination opportunities) and a larger quantity of solution that has to stay stable. These figures assume an ordinary graduated syringe and ignore dead space in the syringe tip, which adds a further small loss at low volumes.
Other points that catch people out
- The cake’s own volume is negligible. Dissolved peptide occupies roughly 0.7 mL per gram, so even 50 mg adds only about 0.04 mL. You can treat the final volume as the diluent volume you added.
- The label mass is peptide content. Use it as the amount in the vial. The report for your batch states the measured quantity if you need the tested figure instead (see the testing page).
- IU is not mg. Some products (such as HCG) are labelled in international units, which depend on the specific substance and cannot be converted to mass with a universal factor. Do the same arithmetic with IU in place of mg.
- Round the concentration, not the measurement. It is easier to pick a diluent volume that gives a round concentration (for example 5 mg/mL) than to work with 3.33 mg/mL every time.
- Re-diluting is a separate step. If you make a more dilute working solution from the reconstituted one, the loss of peptide to the container wall becomes proportionally larger at low concentration, and the effect depends on the peptide and the surface [PMID 21315060]. Use the same type of container each time and note it in your record.
Storage
Storage is where most of a peptide’s useful life is won or lost. The temperatures below are widely used laboratory practice rather than a guarantee for any individual compound; the reasoning behind them is in Why peptides degrade.
| State | Where | Practice |
|---|---|---|
| Lyophilised, unopened, in use within weeks to a few months | Refrigerator, 2–8 °C | Sealed, dark, dry. Keep it in its box or a closed container, away from the door (temperature swings) and from anything that gives off vapours or moisture. |
| Lyophilised, unopened, held for longer | Freezer, −20 °C or colder | Same as above. Avoid a frost-free freezer that cycles warm; a stable, non-defrosting one is better. Let the vial warm to room temperature sealed before opening. |
| Reconstituted in bacteriostatic water | Refrigerator, 2–8 °C | Dark, upright, labelled with the date. Return it to the fridge straight after use rather than leaving it on the bench. |
| Reconstituted in acetic acid water (no preservative) | Refrigerator, 2–8 °C | As above, with fewer entries and a shorter holding time. Prefer single-use aliquots. |
| Reconstituted, aliquoted for later | Freezer, −20 °C or colder | Single-use volumes, frozen once, thawed once. Do not refreeze a thawed aliquot. |
The four enemies: heat, light, moisture and air
- Heat speeds nearly every degradation reaction, so cold is the single most effective protection, in the solid and in solution.
- Light can drive oxidation of residues such as tryptophan, tyrosine, histidine and methionine [PMID 18623513]. Store vials in their box or an opaque container, and do not leave a vial under bright bench lighting.
- Moisture. Water makes the molecules in a dry cake more mobile, and mobile molecules react faster. Studies of freeze-dried proteins show that residual water content and headspace oxygen both affect how fast chemical breakdown and aggregation proceed, with the size of the effect depending on the formulation, and that “as dry as possible” is not always the best state [PMID 1592175, PMID 1592171]. Those studies were on proteins rather than short peptides, so treat them as a guide to the mechanism, not a prediction for a given compound. In practice: keep vials sealed, warm them before opening, and do not open a vial you do not need to open.
- Air. Oxygen is what oxidises methionine, cysteine and other sensitive residues, and trace metal ions catalyse it [PMID 18623513]. Fewer entries and a minimal air gap help.
Freezing a solution
Freezing a reconstituted solution is sometimes useful and sometimes harmful. Freeze-thaw cycles put a peptide through temperature, concentration and ice-surface stresses that can cause aggregation, and the more cycles the greater the risk [PMID 20143256]. If you freeze, freeze once in single-use aliquots, use tubes or vials made of a material you have checked for the compound (surface binding varies by peptide and by container, and siliconised or low-binding surfaces behave differently [PMID 21315060]), and never refreeze.
How long it keeps
You will find confident “good for 30 days” or “stable for 6 months” figures on many websites. For most research peptides there is no published stability study behind them, and stability in solution varies enormously from one sequence to the next. We do not give one universal number for that reason.
What a careful lab does instead:
- Treat the reconstitution date as the start of a countdown and write it on the vial. Pharmacy practice for an opened, preserved multiple-dose vial is a beyond-use date of 28 days (US Pharmacopeia General Chapter <797>, unless a manufacturer states otherwise). That is a convention to limit contamination risk, not a statement that any given peptide stays intact for 28 days. It is a ceiling to work under, not a target.
- Shorten it for a compound that is oxidation-prone (see Reading a sequence), for a vial you enter often, for any solution made with acetic acid water (no preservative), and for anything stored warmer than 8 °C.
- Prefer aliquots for anything you want to keep longer than a few weeks. One thaw, one use.
- If the data matter, measure it. Keep one reconstituted vial, hold it exactly as you store the working vial, and have an aliquot analysed by HPLC against a freshly reconstituted vial of the same lot at the end of your intended period. That is the only way to know what happened to your sample.
- Discard on any visible change: cloudiness, particles, colour, a film or a thread. Visible changes mean it is already well past the point you should be using it. Invisible degradation (oxidation, deamidation) shows no change at all, which is why dates and aliquots matter.
Why peptides degrade
Degradation falls into two groups: chemical (covalent bonds change, so the molecule becomes a different molecule) and physical (the molecule is unchanged but clumps, sticks or unfolds) [PMID 20143256]. Both happen faster in solution than in the dry solid, which is the entire reason for lyophilisation.
| Process | What happens | What speeds it up | What it means in the lab |
|---|---|---|---|
| Oxidation | Methionine, cysteine, histidine, tryptophan and tyrosine are the residues most susceptible to oxidation [PMID 18623513]. Methionine gains an oxygen atom (+16 Da); cysteine thiols can pair into disulfides. | Oxygen, light, trace metals, higher pH and temperature, repeated opening. | Few entries, cold, dark. A new HPLC peak close to the main one, or a mass 16 Da higher (for methionine), is the classic signature. |
| Deamidation | Asparagine (and more slowly glutamine) loses its amide group, passing through a ring intermediate to give aspartate or iso-aspartate [PMID 2395797]. The result is a slightly different mass (+1 Da) and charge. | Neutral to basic pH, higher temperature, certain buffers, and a small neighbour: Asn followed by Gly deamidates fastest. | In one model study, Asn peptides formed the ring intermediate 13 to 36 times faster than the matching Asp peptides, and Gly neighbours were 6.5 to 17.6 times faster than Ala neighbours, at pH 7.4 [PMID 2703484]. |
| Aspartate isomerisation | Aspartate can convert to iso-aspartate through the same ring intermediate, changing the backbone [PMID 2703484]. | The residue after Asp (Gly the worst), pH, temperature. | Same mass, but a different molecule, and one that HPLC may show as a shoulder or a nearby peak. |
| Backbone hydrolysis | A peptide bond is cut. The aspartyl-proline (Asp-Pro) bond is notably more easily cleaved in acid than other X-Pro bonds [PMID 12212803]. | Acidic pH, high temperature, time. | A reminder that “more acidic” is not automatically “more stable”. |
| Aggregation and gelling | Molecules associate into dimers, oligomers or fibrils; solutions turn cloudy, viscous or gel-like. | Agitation, air-liquid interfaces, freeze-thaw, high concentration, pH near the isoelectric point, some preservatives [PMID 20143256, PMID 15614819]. | Gentle swirling only, no foam, avoid unnecessary freeze-thaw, keep the concentration sensible. This is the main reason the acetic acid diluent exists. |
| Adsorption | Peptide sticks to the walls of glass and plastic, so the concentration in solution falls without any chemical change. | Low concentration, certain surfaces, the peptide’s charge and hydrophobicity. Recovery varies by peptide and by container; carrier protein improved recovery in one study and siliconising reduced binding [PMID 21315060]. | Be wary of very dilute working solutions in plastic tubes. Keep the container type consistent between experiments. |
Counter-ions and the “peptide content” figure
Synthetic peptides are usually delivered as salts. The counter-ion (often trifluoroacetate, TFA, left over from purification) contributes to the weight of the powder, which is why peptide content is reported separately from purity. TFA can also affect cell-based work: trifluoroacetate has been reported to inhibit proliferation of osteoblasts and chondrocytes in culture [PMID 10567002]. If you are running cell assays, check the batch report for a TFA result (we publish these for selected batches) and consider including a counter-ion control. The testing page describes which reports are available.
Reading a sequence
You can often anticipate a peptide’s weak points from its amino-acid sequence, using the chemistry above. This is reasoning from general chemistry, not measured stability data for these compounds, and the real behaviour also depends on structure, pH, concentration and handling. Treat it as a way to decide where to be most careful.
| Example | Sequence feature | What it suggests |
|---|---|---|
| Semax | Met-Glu-His-Phe-Pro-Gly-Pro | An N-terminal methionine and a histidine: both oxidation-prone, so limit air and light and avoid repeated entry. |
| MOTS-c | 16 residues containing two methionines, a tryptophan and two tyrosines | Several oxidation-sensitive residues. Cold, dark, short holding time, aliquots. |
| Epitalon | Ala-Glu-Asp-Gly | An aspartate followed by glycine, the combination that isomerises fastest in model studies [PMID 2703484]. Do not hold it warm or for long periods. |
| DSIP | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | An N-terminal tryptophan (light and oxidation) and an aspartate. Protect from light. |
| Glutathione | γ-Glu-Cys-Gly | A free cysteine thiol, which readily oxidises to the disulfide (GSSG) in air. Minimise oxygen and time in solution. |
| GHK-Cu | Gly-His-Lys with a copper(II) ion | Histidine coordinates the copper. It is listed at the mildly acidic pH 5.7, and the metal can itself drive oxidation, so keep it in the dark and cold. |
Troubleshooting
If you are unsure whether a solution is fit for use, it is not. Quarantine the vial, keep the label, and contact us with the lot number and a clear photo.
| What you see | Likely reasons | What to do |
|---|---|---|
| Lots of foam or bubbles | Diluent added too fast or onto the cake; vial shaken. | Let it stand cold and undisturbed until the foam settles. Next time, add it down the wall, slowly. |
| A few small undissolved flecks that dissolve with a gentle swirl | Normal slow dissolution of a thick cake. | Swirl gently and wait. Do not heat or shake. |
| Persistent haze, cloudiness or particles | Incomplete dissolution, aggregation, the wrong diluent or pH for the compound, or contamination. | Do not use it. Do not warm it to clear it. Contact us with the lot number. If the compound lists an acetic acid option, tell us which diluent you used. |
| Gel, strings or a thick consistency | Aggregation or gelling, which some compounds are prone to in a given diluent. | Do not use it. Contact us; this is the situation the acetic acid diluent exists for, so check the compound’s product page. |
| Yellow or brown colour | Oxidation, contamination, or a degraded sample. | Do not use it. Note the lot and how long it was stored. |
| Cloudy after it was clear and refrigerated | Aggregation, microbial growth, or cold-induced precipitation. | Discard. Warming a cloudy vial back to clear does not make it safe: aggregation is not always reversible. |
| Dry cake looks collapsed, melted, discoloured or stuck high on the glass | Heat or moisture exposure, or an irregular freeze-drying cycle. | Do not reconstitute. Contact us with a photo. A film coating the glass is normal; a collapsed or discoloured cake is not. |
| Little or no cake visible | Small peptide mass dispersed as a thin film, which is normal for vials of a few milligrams. | Reconstitute as normal and rinse the wall by swirling. |
| Stopper damaged, cored or leaking | Too many entries, a blunt or reused syringe tip, or a damaged seal. | Do not store the vial for later; use it promptly or discard it. |
Labelling and records
A well-labelled vial lets you reconstruct what happened to a sample months later. Put these on the vial, or in a log keyed to a number on it:
- Compound and the batch name from the label, matching the COA library entry.
- Date and time reconstituted, and by whom.
- Diluent (which of the three), its bottle or lot, and the volume added.
- Resulting concentration in mg/mL (and mcg/mL if you work in mcg).
- Storage location and a beyond-use date.
- For aliquots: how many, what container, and the date frozen.
Keep waste and used sharps in a proper sharps container and dispose of them as your local rules require. Use gloves and eye protection when handling any laboratory chemicals.
Common questions
Can I shake or vortex the vial to dissolve it faster?
No. Agitation and foam create air-liquid interfaces where peptides and proteins can unfold and aggregate [PMID 20143256]. Gentle swirling and a few minutes’ patience is quicker than dealing with a gel.
Can I use a different diluent from the one listed?
We only supply and have assessed the three diluents in this guide. Use the one listed on the compound’s product page. If you want to try a different one of ours, do it on a test vial first, not your only sample, and record the result.
Why does the vial look nearly empty?
A few milligrams of freeze-dried peptide is a very small volume of material, often a thin film or a tiny pellet. An empty-looking vial that dissolves into the stated volume of clear solution is normal. A batch report states the quantity found.
Should I reconstitute the whole vial or part of it?
The whole vial. A lyophilised vial cannot be accurately divided dry, and the concentration maths assumes everything in the vial is dissolved. To keep part of the material dry for longer, plan aliquots after reconstitution instead.
Is a short time at room temperature a problem?
For a lyophilised vial, short periods (for example in transit, or while you are working) are generally tolerated. For a reconstituted solution, room temperature speeds degradation and microbial growth, so put it back in the fridge when you finish.
How do I know it has not degraded?
You cannot tell by eye. Chemical degradation such as oxidation and deamidation leaves a clear, colourless solution. HPLC against a fresh vial is the real test, and mass spectrometry shows what changed. See the testing page for what our reports show.
Sources
The papers below are cited above by PubMed ID. Several study proteins (growth hormone, interleukin-1 receptor antagonist, plasminogen activator) or model peptides rather than the specific compounds we sell, so they support the general mechanisms rather than any claim about a particular product. Storage temperatures, aliquoting and beyond-use dating are described as common laboratory practice. The 28-day figure is from US Pharmacopeia General Chapter <797>.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010. PMID 20143256
- Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995. PMID 18623513
- Patel K, Borchardt RT. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm Res. 1990. PMID 2395797
- Stephenson RC, Clarke S. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J Biol Chem. 1989. PMID 2703484
- Skribanek Z, Mezo G, Mák M, Hudecz F. Mass spectrometric and chemical stability of the Asp-Pro bond in herpes simplex virus epitope peptides compared with X-Pro bonds of related sequences. J Pept Sci. 2002. PMID 12212803
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011. PMID 21315060
- Roy S, Jung R, Kerwin BA, Randolph TW, Carpenter JF. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. J Pharm Sci. 2005. PMID 15614819
- Hsu CC, Ward CA, Pearlman R, Nguyen HM, Yeung DA, Curley JG. Determining the optimum residual moisture in lyophilized protein pharmaceuticals. Dev Biol Stand. 1992. PMID 1592175
- Pikal MJ, Dellerman K, Roy ML. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev Biol Stand. 1992. PMID 1592171
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999. PMID 10567002
Last reviewed: 20 November 2026
Research use only. This guide is general laboratory reference information and does not make any product suitable or safe for human use.
